Antisense oligonucleotides: towards clinical trials
- 1 October 1996
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 14 (10) , 376-387
- https://doi.org/10.1016/0167-7799(96)10053-6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modificationsNucleic Acids Research, 1996
- Transient Decrease in High Blood Pressure by In Vivo Transfer of Antisense Oligodeoxynucleotides Against Rat AngiotensinogenHypertension, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in ratsExperimental and Clinical Endocrinology & Diabetes, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-o- methyloligoribonucleotidesBioorganic & Medicinal Chemistry Letters, 1994
- Serum immunoglobulins interact with oligonucleotidesFEBS Letters, 1994
- Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cellsBiochemistry, 1993
- Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotideBiochemical and Biophysical Research Communications, 1992
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992